Natera, Inc.


SKU: NTRA Category:


Natera, Inc.: Initiation Of Coverage – Can It Successfully Leverage The Invitae Acquisition? 


Natera, Inc.’s latest quarterly earnings reveal positive growth prospects and the firm’s commitment to maintaining momentum in their healthcare ventures. The company saw a rise in revenue, reaching $311 million for Q4, a substantial growth of 43% over the same period in 2022. Furthermore, its full-year revenues were reported at $1.08 billion, up by more than 30% compared to the previous year. These results come on the back of the company processing a significantly higher number of tests in 2023, suggesting a strong demand for the company’s services.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!